Assembly Biosciences Inc expected to post a loss of 23 cents a share - Earnings Preview

Assembly Biosciences

03/11/2023 12:45

* Assembly Biosciences Inc  ASMB.OQ   ASMB.O  is expected
to show
no change in quarterly revenue when it reports  results 
    * 
    * ​Refinitiv's mean analyst estimate for Assembly
Biosciences Inc
is for a loss of 23 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Assembly
Biosciences Inc is $3​, above​ its last closing price of $0.87.
​​​

This summary was machine generated November 3 at 12:45 GMT.  All
figures in US dollars  unless otherwise stated